-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NWLn6pSjqYWxaP7hCHzBaXZeUmpVEpr2KB84s8bOHoutDdq7NH7KaRbUiJfPVkyo RaVo7za2s9I9PsqZSAET7w== 0001144204-10-035204.txt : 20100625 0001144204-10-035204.hdr.sgml : 20100625 20100625171956 ACCESSION NUMBER: 0001144204-10-035204 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100625 DATE AS OF CHANGE: 20100625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SKYSTAR BIO-PHARMACEUTICAL CO CENTRAL INDEX KEY: 0001076939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330901534 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-167240 FILM NUMBER: 10918301 BUSINESS ADDRESS: STREET 1: RM 10601, JIEZUO PLAZA, NO. 4 STREET 2: FENGHUI ROAD SOUTH, GAOXIN DISTRICT CITY: XIAN PROVINCE STATE: F4 ZIP: 00000 BUSINESS PHONE: 407-645-4433 MAIL ADDRESS: STREET 1: RM 10601, JIEZUO PLAZA, NO. 4 STREET 2: FENGHUI ROAD SOUTH, GAOXIN DISTRICT CITY: XIAN PROVINCE STATE: F4 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: CYBER GROUP NETWORK CORP DATE OF NAME CHANGE: 20000711 RW 1 v189028_rw.htm
Skystar Bio-Pharmaceutical Company
Rm. 10601, Jiezuo Plaza, No. 4, Fenghui Road South,
Gaoxin District, Xi’an, Shaanxi Province, P.R. China

June 25, 2010


Via EDGAR

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington D.C., 20549

Re:
Skystar Bio-Pharmaceutical Company
Request to Withdraw Registration Statement
Registration No. 333-167240
 

Ladies and Gentlemen:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Skystar Bio-Pharmaceutical Company (the “Company”) hereby respectfully requests the withdrawal of its registration statement on Form S-1, initially filed on June 1, 2010 (the “Registration Statement”).

No securities have been issued or sold under the Registration Statement.  The reason for this withdrawal is that, in light of current market conditions, the Company has decided not to pursue the public offering of its common stock described in the Registration Statement.  The Company also requests, in accordance with Rule 457(p) of the Securities Act, that all fees paid to the Securities and Exchange Commission in connection with the filing of the Registration Statement be credited for future use.

Please contact the Company’s legal counsel, Rahul P. Dange at Richardson & Patel LLP at (310) 208-1182, if you have any questions.

Thank you for your assistance in this matter.


                                                     
Very truly yours,
   
 
SKYSTAR BIO-PHARMACUETICAL COMPANY
   
   
 
/s/ Michael H. Lan                 
 
Michael H. Lan
 
Chief Financial Officer

-----END PRIVACY-ENHANCED MESSAGE-----